Healthcare Services

Malaria Vaccines Market Outlook Highlighting Key Drivers and Market Evolution

April 23, 2026April 26, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Malaria Vaccines Market Between 2026 And 2030?

The malaria vaccines market has experienced substantial expansion in recent years. It is projected to increase from $6.24 billion in 2025 to $8.36 billion in 2026, achieving a compound annual growth rate (CAGR) of 33.9%. The historical growth can be attributed to several factors, including the high malaria burden in endemic regions, long-standing global malaria eradication initiatives, funding support from international health organizations, limitations of antimalarial drug resistance, and the early success of first-generation malaria vaccines.

The malaria vaccines market is projected to experience rapid expansion over the coming years, with its size anticipated to reach $27.18 billion by 2030, growing at a compound annual growth rate (CAGR) of 34.3%. This growth during the forecast period can be attributed to factors such as increased government funding for the prevention of infectious diseases, the climate-driven expansion of malaria-prone areas, a rising demand for vaccines that provide long-lasting immunity, continuous advancements in vaccine research and clinical trials, and the broadening of immunization coverage in low-income countries. Key trends expected in the forecast period include the expansion of next-generation malaria vaccines, a heightened focus on pediatric immunization programs, a surge in public-private partnerships for vaccine deployment, an increasing emphasis on multi-antigen and combination vaccines, and the strengthening of mass vaccination campaigns in regions where the disease is endemic.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13698&type=smp

Which Key Factors Are Driving The Malaria Vaccines Market Growth?

The increasing prevalence of mosquito-related illnesses is anticipated to drive the expansion of the malaria vaccine market in the future. These encompass a wide range of sicknesses transmitted through the bite of an infected mosquito. Specifically, the RTS, S/AS01 (RTS, S) malaria vaccine functions by instructing the immune system to identify and combat the parasite, thereby preventing and mitigating the effects of mosquito-borne infectious diseases. As an illustration, the UK Health Security Agency (UKHSA), a government department based in the UK, indicated in December 2024 that its 2023 annual malaria report recorded 2,106 imported malaria cases in the UK. This figure represents a 26% increase compared to the cases documented in 2022. Consequently, the growing occurrence of mosquito-related diseases is a significant factor boosting the growth of the malaria vaccine market.

How Is The Malaria Vaccines Market Categorized Across Its Segment Groups?

The malaria vaccines market covered in this report is segmented –

1) By Agent: Plasmodium Falciparum, Plasmodium Vivax

2) By Vaccine Type: Pre-Erythrocytic, Erythrocytic, Multi-antigen, Other Vaccines

3) By Route Of Administration: Intramuscular, Subcutaneous, Intradermal, Other Routes Of Administration

4) By Distribution Channel: Public, Private

Subsegments:

1) By Plasmodium Falciparum: RTS,S/AS01 Vaccine, Experimental Vaccines

2) By Plasmodium Vivax: Candidate Vaccines In Development, Combination Vaccines

Which Trends Are Guiding The Direction Of The Malaria Vaccines Market?

Companies operating significantly within the malaria vaccines market are prioritizing the development of inventive solutions, notably next-generation recombinant vaccines. This focus aims to satisfy the increasing demand propelled by rising malaria prevalence, governmental support, and expanding immunization initiatives. Next-generation recombinant vaccines employ advanced genetic engineering techniques to target multiple stages of the malaria parasite’s life cycle, leading to improved immune responses and more sustained protection compared to conventional vaccines that often target a single stage and provide limited efficacy. For example, in October 2025, the Government of the Republic of Zambia introduced the malaria vaccine R21/Matrix-M as part of its Expanded Programme on Immunisation. This vaccine, a collaborative effort by the University of Oxford and the Serum Institute of India, utilizes a recombinant protein platform integrated with the Matrix-M adjuvant to strengthen the immune response. It is administered in a four-dose schedule beginning from 6 months of age and is conceived to complement existing anti-malaria interventions. The vaccine exhibits higher efficacy rates and intends to safeguard children in high and moderate transmission districts across Zambia, contributing considerably to malaria eradication endeavors.

Which Firms Are Influencing Competition In The Malaria Vaccines Market?

Major companies operating in the malaria vaccines market are GlaxoSmithKline Plc, Bharat Biotech International Limited, Serum Institute of India Private Limited, Sanaria Inc, BioNTech SE, Moderna Inc, Pfizer Inc, Novavax Inc, Takeda Pharmaceutical Company Limited, Sanofi SA, Zydus Lifesciences Limited, Valneva SE, GeoVax Labs Inc, Inovio Pharmaceuticals Inc, Vaxart Inc, CanSino Biologics Inc, Sinovac Biotech Ltd, Clover Biopharmaceuticals Inc, Biological E Limited, Emergent BioSolutions Inc

Get The Full Malaria Vaccines Market Report:

https://www.thebusinessresearchcompany.com/report/malaria-vaccines-global-market-report

Which Region Dominates The Malaria Vaccines Market By Market Share?

North America was the largest region in the malaria vaccines market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the malaria vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Malaria Vaccines Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/malaria-vaccines-global-market-report

Browse Through More Reports Similar to the Global Malaria Vaccines Market 2026, By The Business Research Company

Generalized Anxiety Disorder Market Report 2026

https://www.thebusinessresearchcompany.com/report/generalized-anxiety-disorder-global-market-report

Antidepressant Market Report

https://www.thebusinessresearchcompany.com/report/antidepressant-global-market-report

Panic Disorders Market Report

https://www.thebusinessresearchcompany.com/report/panic-disorders-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795